Annals of oncology : official journal of the European Society for Medical Oncology · 2015
2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.
Consensus StatementСтатьяКлинические рекомендацииОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Eberhardt W E E, De Ruysscher D, Weder W, Le Péchoux C, De Leyn P, Hoffmann H, Westeel V, Stahel R, Felip E, Peters S, Panel Members
Аннотация
To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on Lung Cancer was held on 11-12 May 2013 in Lugano. A total of 35 experts met to address several questions on non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, first-line/second and further lines of treatment in advanced disease, early-stage disease and locally advanced disease. For each question, recommendations were made including reference to the grade of recommendation and level of evidence. This consensus paper focuses on locally advanced disease.
Предметные рубрики MeSH
Antineoplastic Combined Chemotherapy ProtocolsBronchoscopyCarboplatinCarcinoma, Non-Small-Cell LungChemotherapy, AdjuvantCisplatinDisease ManagementEndoscopic Ultrasound-Guided Fine Needle AspirationEtoposideEuropeHumansLungLung NeoplasmsLymph NodesMediastinumMultimodal ImagingPneumonectomyPositron-Emission TomographyRadiotherapy, AdjuvantSocieties, MedicalTomography, X-Ray ComputedVinblastineVinorelbine